These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 18320916

  • 1. Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting.
    Lee-Wong M, Chou V, Ogawa Y.
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):146-52. PubMed ID: 18320916
    [Abstract] [Full Text] [Related]

  • 2. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
    LaForce C, Prenner BM, Andriano K, Lavecchia C, Yegen U.
    J Asthma; 2005 Mar; 42(2):101-6. PubMed ID: 15871441
    [Abstract] [Full Text] [Related]

  • 4. A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma.
    Najafizadeh K, Sohrab Pour H, Ghadyanee M, Shiehmorteza M, Jamali M, Majdzadeh S.
    Emerg Med J; 2007 May; 24(5):317-21. PubMed ID: 17452695
    [Abstract] [Full Text] [Related]

  • 5. A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.
    Bensch G, Lapidus RJ, Levine BE, Lumry W, Yegen U, Kiselev P, Della Cioppa G.
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):19-27. PubMed ID: 11206232
    [Abstract] [Full Text] [Related]

  • 6. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
    Sill V, Bartuschka B, Villiger B, Ortland C, Domej W.
    Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
    [Abstract] [Full Text] [Related]

  • 7. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 8. Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial.
    Pleskow W, LaForce CF, Yegen U, Matos D, Della Cioppa G.
    J Asthma; 2003 Apr; 40(5):505-14. PubMed ID: 14529100
    [Abstract] [Full Text] [Related]

  • 9. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I, Hall IP, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 11. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004 Sep; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 12. Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations.
    Rodriguez E, Vera V, Perez-Puigbo A, Capriles-Hulett A, Ferro S, Manrique J, Abate J.
    Allergol Immunopathol (Madr); 2008 Sep; 36(4):196-200. PubMed ID: 18928685
    [Abstract] [Full Text] [Related]

  • 13. Formoterol Turbuhaler as reliever medication in patients with acute asthma.
    Rubinfeld AR, Scicchitano R, Hunt A, Thompson PJ, Van Nooten A, Selroos O.
    Eur Respir J; 2006 Apr; 27(4):735-41. PubMed ID: 16455838
    [Abstract] [Full Text] [Related]

  • 14. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study.
    Aalbers R, Brusselle G, McIver T, Grothe B, Bodzenta-Lukaszyk A.
    Adv Ther; 2012 Nov; 29(11):958-69. PubMed ID: 23081745
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D, Vicaut E, Lefrançois G, Formoterol HFA group.
    Respiration; 2005 Nov; 72 Suppl 1():20-7. PubMed ID: 15915009
    [Abstract] [Full Text] [Related]

  • 16. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U, Viktrup L, Davidsen O, Viskum K.
    Ugeskr Laeger; 1992 Nov 16; 154(47):3325-8. PubMed ID: 1361083
    [Abstract] [Full Text] [Related]

  • 17. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
    Wallin A, Sandström T, Rosenhall L, Melander B.
    Thorax; 1993 Jun 16; 48(6):611-4. PubMed ID: 8346490
    [Abstract] [Full Text] [Related]

  • 18. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children.
    Watanasomsiri A, Phipatanakul W.
    Ann Allergy Asthma Immunol; 2006 May 16; 96(5):701-6. PubMed ID: 16729783
    [Abstract] [Full Text] [Related]

  • 19. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol.
    Blais L, Beauchesne MF, Forget A.
    Respir Med; 2009 Feb 16; 103(2):237-43. PubMed ID: 18930647
    [Abstract] [Full Text] [Related]

  • 20. A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting.
    Bussamra MH, Stelmach R, Rodrigues JC, Cukier A.
    Ann Allergy Asthma Immunol; 2009 Sep 16; 103(3):248-53. PubMed ID: 19788023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.